Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NSE - Delayed Quote • INR Avonmore Capital & Management Services Limited (AVONMORE.NS) Follow Add holdings 20.81 -0.43 (-2.02%) At close: 3:15:08 PM GMT+5:30 Related News Netflix, Disney stocks slide as Trump threatens 100% tariff on foreign-made films Netflix, Disney, and other media stocks fell after President Trump proposed a 100% tariff on foreign-made films. The three-year returns have been enviable for Axsome Therapeutics (NASDAQ:AXSM) shareholders despite underlying losses increasing Investing can be hard but the potential fo an individual stock to pay off big time inspires us. But when you hold the... Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer SAN FRANCISCO, May 05, 2025--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Nader Kabbani as Chief Operations Officer.1 A seasoned executive known for scaling trusted consumer and healthcare logistics businesses, Kabbani will oversee operations as the company expands access to personalized care for millions more individuals. Tyson Foods Misses the Mark on Sales Tyson Foods reported strong earnings for the latest quarter, but sales failed to meet expectations, showing nearly no growth compared with a year before. On Monday morning, Tyson reported 92 cents in adjusted earnings for its second fiscal quarter, which ended on March 29. With the exception of chicken, a winner in the prior quarter as well, sales volume in all segments fell from the year before. These Stocks Are Moving the Most Today: Berkshire Hathaway, Microsoft, Apple, Netflix, Palantir, Tyson Foods, and More Berkshire Hathaway’s Class B shares fall after Warren Buffett says he’ll be stepping down as CEO at the end of the year, Microsoft kicks off Monday as the largest U.S. company by market cap, Netflix falls as President Donald Trump says he authorized a 100% tariff on films produced overseas. Palantir Technologies, meanwhile, is scheduled to report quarterly earnings Monday. Cummins Beats Earnings Estimates But Withdraws Full-Year Guidance Due to Tariffs CEO Jennifer Rumsey cited “growing economic uncertainty driven by tariffs” for withdrawing guidance. Berkshire Hathaway (BRK.B) Sits on $300B Cash Pile, Plays the Long Game in Japan Buffett says no to rushed deals, yes to patience and partnerships Cummins withdraws 2025 financial forecast on tariff woes "Due to growing economic uncertainty, the company is not providing an outlook for revenue or profitability for the remainder of 2025" Cummins said in its earnings release. The North American trucking market, already dealing with an oversupply of equipment, is now confronted with new challenges arising due to the erratic import tariffs. General Motors pulled its annual forecast earlier this month, days after pausing plans to buy back $2 billion of shares in the first half of the year. Tyson Foods Sales Flat on Mixed Volumes Tyson Foods said sales in its fiscal second quarter were unchanged year-over-year as higher volumes in its chicken business were balanced out by declines in beef and other segments. ON Semiconductor Stock Climbs on Better-Than-Expected Earnings FEATURE ON Semiconductor stock climbed in premarket trading Monday after first-quarter earnings and revenue surpassed analysts’ expectations. The Scottsdale, Ariz.-based chip maker posted adjusted earnings of 55 cents a share, beating analysts’ calls for 50 cents, according to FactSet. Berkshire Hathaway (BRK.A) Surges as Buffett Prepares Exit After 60 Years Greg Abel to succeed Buffett amid record cash pile and market outperformance Tyson Foods stock falls as revenue misses estimates Investing.com -- Tyson Foods, Inc. reported mixed second-quarter results on Monday, with earnings beating expectations but revenue falling short of analyst estimates. The stock dropped 3.9% following the release. TG Therapeutics (TGTX) Lags Q1 Earnings Estimates TG Therapeutics (TGTX) delivered earnings and revenue surprises of -83.33% and 1.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock? ON Semiconductor Corp.: Q1 Earnings Snapshot SCOTTSDALE, Ariz. AP) — ON Semiconductor Corp. ON) on Monday reported a loss of $486.1 million in its first quarter. onsemi (NASDAQ:ON) Reports Strong Q1, Provides Encouraging Quarterly Revenue Guidance Analog chips maker onsemi (NASDAQ:ON) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 22.4% year on year to $1.45 billion. Guidance for next quarter’s revenue was optimistic at $1.45 billion at the midpoint, 2.5% above analysts’ estimates. Its non-GAAP profit of $0.55 per share was 9.6% above analysts’ consensus estimates. onsemi Reports First Quarter 2025 Results SCOTTSDALE, Ariz., May 05, 2025--onsemi (the "Company") (Nasdaq: ON) today announced its first quarter 2025 results with the following highlights: Ackman’s Pershing Square to Boost Stake in Howard Hughes Holdings Howard Hughes Holdings said Bill Ackman’s Pershing Square Capital Management will invest $900 million in the company, boosting its stake further and bringing Ackman back into the fold. Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab) The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025SELARSDI is approved for all indications matching the reference productSELARSDI is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients with moderately to seve Greg Abel’s Challenge: Lead Berkshire Into a New Era Without the Buffett Touch Warren Buffett has done what he can to prepare his successor at Berkshire Hathaway. But there is one thing that can’t be simply handed off: the Buffett brand. Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. Builds upon Firefly’s recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announce its acquisition of Evoke Neuroscie Performance Overview Trailing total returns as of 5/5/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) Return AVONMORE.NS S&P BSE SENSEX (^BSESN) YTD +16.39% +3.40% 1-Year +74.07% +9.37% 3-Year +158.51% +45.05%